Literature DB >> 9579832

The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.

J C Fox1, J England, P White, G Ellison, K Callaghan, N R Charlesworth, J Hehir, T L McCarthy, J Smith-Ravin, I C Talbot, D Snary, J M Northover, C R Newton, S Little.   

Abstract

A total of 301 colorectal carcinoma (CRC) archival samples were analysed using the amplification-refractory mutation system (ARMS). Each sample was examined to determine the mutation status of codons 12 and 13 of the K-ras oncogene. The results from direct DNA sequence analysis carried out on 30 of the samples differed from the ARMS result in almost 50% of the cases as a result of the relative excess of wild-type to mutated DNA sequences. To assess the validity of the ARMS data, the polymerase chain reaction (PCR) was used to generate an amplicon from K-ras exon 1 from 23 of the samples. The PCR amplicons were cloned and sequenced, and the DNA sequence analysis of the cloned material was in agreement with the ARMS results in all but one case. This case represented a tumour that exhibited a five-nucleotide reversed inversion. The cloned sequence data confirm the sensitivity and specificity of the individual ARMS reactions and that it is possible in certain cases to detect additional, more complex, sequence variations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579832      PMCID: PMC2150152          DOI: 10.1038/bjc.1998.212

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  61 in total

1.  Detection of ras point mutations by polymerase chain reaction using mutation-specific, inosine-containing oligonucleotide primers.

Authors:  T Ehlen; L Dubeau
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

2.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

3.  An analytical method for assessing patterns of familial aggregation in case-control studies.

Authors:  L P Zhao; L Le Marchand
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

4.  Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products.

Authors:  C R Newton; N Kalsheker; A Graham; S Powell; A Gammack; J Riley; A F Markham
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

5.  Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis.

Authors:  S D Finkelstein; R Sayegh; A Bakker; P Swalsky
Journal:  Arch Surg       Date:  1993-05

6.  Genetic heterogeneity and unmapped genes for colorectal cancer.

Authors:  C M Lewis; S L Neuhausen; D Daley; F J Black; J Swensen; R W Burt; L A Cannon-Albright; M H Skolnick
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

7.  K-ras-2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas.

Authors:  W Giaretti; N Pujic; A Rapallo; S Nigro; A Di Vinci; E Geido; M Risio
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

8.  Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver.

Authors:  J J Oudejans; R J Slebos; F A Zoetmulder; W J Mooi; S Rodenhuis
Journal:  Int J Cancer       Date:  1991-12-02       Impact factor: 7.396

9.  A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients.

Authors:  M Span; P T Moerkerk; A F De Goeij; J W Arends
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

10.  Molecular pathology of haemophilia B.

Authors:  P M Green; D R Bentley; R S Mibashan; I M Nilsson; F Giannelli
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more
  13 in total

1.  DNA enrichment by allele-specific hybridization (DEASH): a novel method for haplotyping and for detecting low-frequency base substitutional variants and recombinant DNA molecules.

Authors:  Alec J Jeffreys; Celia A May
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

Review 2.  KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

Authors:  J H J M van Krieken; A Jung; T Kirchner; F Carneiro; R Seruca; F T Bosman; P Quirke; J F Fléjou; T Plato Hansen; G de Hertogh; P Jares; C Langner; G Hoefler; M Ligtenberg; D Tiniakos; S Tejpar; G Bevilacqua; A Ensari
Journal:  Virchows Arch       Date:  2008-09-18       Impact factor: 4.064

3.  Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.

Authors:  Maria Arcila; Christopher Lau; Khedoudja Nafa; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

4.  Optimized allele-specific real-time PCR assays for the detection of common mutations in KRAS and BRAF.

Authors:  Alois H Lang; Heinz Drexel; Simone Geller-Rhomberg; Nicole Stark; Thomas Winder; Kathrin Geiger; Axel Muendlein
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

5.  Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.

Authors:  N T van Heek; S J Clayton; P D J Sturm; J Walker; D J Gouma; L A Noorduyn; G J A Offerhaus; J C Fox
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

6.  KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.

Authors:  Wilbur A Franklin; Jerry Haney; Michio Sugita; Lynne Bemis; Antonio Jimeno; Wells A Messersmith
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

7.  A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples.

Authors:  Gillian Ellison; Emma Donald; Gael McWalter; Lucy Knight; Lynn Fletcher; James Sherwood; Mireille Cantarini; Maria Orr; Georgina Speake
Journal:  J Exp Clin Cancer Res       Date:  2010-10-06

8.  Comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'.

Authors:  D Tougeron; P Laurent-Puig; A Zaanan
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

9.  Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.

Authors:  Jun-Fu Huang; Dong-Zhu Zeng; Guang-Jie Duan; Yan Shi; Guo-Hong Deng; Han Xia; Han-Qing Xu; Na Zhao; Wei-Ling Fu; Qing Huang
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

10.  DEspR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: a 'common receptor coordinator' paradigm.

Authors:  Victoria L Herrera; Julius L Decano; Glaiza A Tan; Ann M Moran; Khristine A Pasion; Yuichi Matsubara; Nelson Ruiz-Opazo
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.